Clinical Trial Update: Combination of TATE and PD-1 Inhibitor in Liver Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial updating on the combination of TATE and a PD-1 inhibitor for hepatocellular carcinoma and gastric cancer, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Hepatocellular Carcinoma

Drugs mentioned

• PD-1 inhibitor
• TATE

Snippet

Sponsor: Teclison Ltd. | Conditions: Hepatocellular Carcinoma, Gastric Cancer | Phase 2 | Status: RECRUITING